Peri-Prosthetic Joint Infection: Prevention, Diagnosis and Management by Gheiti, Adrian J. Cassar & Mulhall, Kevin J.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 22
Peri-Prosthetic Joint Infection:
Prevention, Diagnosis and Management
Adrian J. Cassar Gheiti and Kevin J. Mulhall
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/53247
1. Introduction
Total Joint Arthroplasty (TJA) is a safe and effective procedure that improves the quality of life
and restores function in most patients suffering from joint arthritis. Post-operative peri-prosthet‐
ic joint infections (PJI) are an uncommon and difficult complication of joint replacement surgery.
PJI affects 1-3% total joint replacements and is the most common indication for revision in total
knee arthroplasty (TKA) and third most common indication for revision total hip arthroplasty
(THA)[1-4]. PJI can be difficult to diagnose and can present at any time from the primary proce‐
dure[5, 6]. PJI is painful, disabling, costly and often requires multiple procedures[7], prolonged
periods of rehabilitation, antibiotic treatment and poor functional outcome. It places a considera‐
ble burden on hospital and surgeon resources with an estimated annual cost of infected revisions
in US hospitals increasing from $320 million in 2001 to $566 million in 2009, with a projected cost
exceeding $1.62 billion by 2020[8]. Consistent efforts at prevention are mandatory, and treatment
of infection requires appropriate assessment of its chronicity and causative factors, the status of
the wound and the overall health of the patient.
We will first provide an overview on peri-prosthetic joint infection and the possible risk fac‐
tors involved. Finally, we will provide an overview of the current evidence available in pre‐
venting, diagnosis and managing peri-prosthetic joint infection.
2. Pathophysiology
Peri-prosthetic joint infections are a result of an intricate interaction between the host, the
pathogen and the implant[9-11]. There is a multitude of host factors, ranging from medical
comorbidities to social economic status, which increase the risk of PJI[9, 10, 12-15].
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2.1. Host and environmental factors
Predisposing factors for PJI can be sub classified into preoperative, intraoperative and post‐
operative factors (Table 1). Preoperative predisposing factors include medical conditions
such as diabetes, inflammatory arthropathies, preoperative anemia, congestive heart disease
and chronic pulmonary disease to mention few[9, 10, 12, 14]. Intraoperative predisposing
factors include simultaneous bilateral joint arthroplasty, longer operative time, knee arthro‐
plasty, increased operating room traffic and contamination by the surgical team during
preparation and draping[12, 16-19].
Post-operative predisposing factors to PJI include immunosuppressive medications, allogen‐
ic blood transfusion, post-operative atrial fibrillation, myocardial infarction, urinary tract in‐
fection and longer hospital stay[9, 10, 12].
Peri-prosthetic  joint  infections are typically caused by microorganisms that  grow in bio‐
films[36].  Within  biofilms,  microorganisms in  a  polymetric  matrix  and develop into  or‐
ganized  complex  communities  resembling  a  multicellular  organism[37].  In  a  biofilm,
microbes are protected from antimicrobial agents and host immune responses. This may
be related to the reduced growth rate of biofilm microorganisms, which enter a station‐
ary phase of growth[38]. Different microbes have different interactions with the host and
the prosthetic. Some have specific adhesion molecules which help them adhere to the im‐
plant until a biofilm is formed, which is mediated in part by intracellular adhesion mole‐
cules[39].  Initially,  adherent  microorganisms  and  early  biofilms  are  relatively  unstable
and  still  susceptible  to  host  defense  and  antimicrobial  agents.  In  contrast,  mature  bio‐
films are more stable and resist  to elimination[40].  Furthermore,  implants  are devoid of
microcirculation, which is crucial for the immune system and antibiotics to interact with
microbes.  Implants  also  tend to  activate  neutrophils  which release  peptides  that  deacti‐
vate granulocytes, impairing the removal of microbes[41]. This effect on granulocytes re‐
duces  the  minimal  amount  of  microbes  that  are  required  to  cause  an  infection[41].
Inoculation of implants, not only occurs during the time of surgery, but can occur in the
presence of a bacteremia from any source in the human body during the entire lifetime
of the implant[42].
2.2. Microbial profile in PJI
A multitude of organisms mostly bacteria and fungi are reported to cause PJI (Table.2). The
most reported organisms responsible for PJI are Gram positive cocci, most commonly Staphy‐
lococcus Aureus and Staphylococcus Epidermidis as reported by various authors[12, 20, 22, 31,
43-45]. On certain occasions, Gram negative bacteria and Fungi can also be responsible for
periprosthetic joint infections[46, 47]. In a recent study published by Buller et al., Methicillin
Resistant Staph. Aureus (MRSA) and Methicillin Resistant Staph. Epidermidis (MRSE) account
for about 15.5% of all PJIs[20] and according to other studies up to 19% of PJIs can be poly
microbial[12, 22, 48]. These microorganisms can all be part of normal skin flora; hence, direct
inoculation at the time of the operation as well as airborne contamination are the most likely
causes of these infections.
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Predisposing Factors Studies
Preoperative
Male sex Buller et al.[20], Jämsen et al.[21]
Socioeconomic status Pulido et al.[12], Berbari et al.[22]
ASA > 2 Pulido et al.[12], Buller et al.[20], Bozic et al.[9], Saleh et al.[23],
Diabetes and elevated blood sugars Buller et al.[20], Bozic et al.[9], Jämsen et al.[24], Berbari et al[22].,
Saleh et al.[23]
Inflammatory Arthropathy Pulido et al.[12], Bozic et al.[9], Wilson et al.[10], Jämsen et al.[21] ,
Berbari et al.[22]
Immunosuppressant medication Wilson et al.[10], Berbari et al.[22], Saleh et al.[23]
Preoperative Anaemia Pulido et al.[12], Greenky et al.[14], Bozic et al.[9]
Poor Nutrition Berbari et al.[22]
Higher BMI Pulido et al.[12], Bozic et al.[9]
Other infected Joint Arthroplasty Buller et al.[20], Jafari et al.[15], Berbari et al.[22]
History of malignancy/metastasis Bozic et al.[9], Berbari et al.[22]
Skin ulcers/PVD Bozic et al.[9], Wilson et al.[10], Berbari et al.[22], Poss et al.[25]
Intraoperative
Knee arthroplasty Pulido et al.[12], Buller et al.[20]
Simultaneous bilateral Pulido et al.[12]
Longer operative time Pulido et al.[12], Muilwijk et al.[26], Ong et al.[27], Berbari et al.[22],
Saleh et al.[23]
No prophylactic antibiotic Fogelberg et al.[28], Pavel et al.[29], Meehan et al.[30], Al-Maiyah et
al.[31]
Cement with no antibiotics Hanssen AD.[32], Jämsen et al.[21]
Skin Preparation and Draping Johnson et al.[33], Katthagen et al.[16]
Contamination by operating room personnel Ayers et al.[34], Rao et al.[35]
Operating Room Traffic Panahi et al.[18]
Postoperative
Renal impairment Pulido et al.[12], Saleh et al.[23], Bozic et al.[9]
Allogenic blood transfusion Pulido et al.[12], Berbari et al.[22], Saleh et al.[23]
Myocardial Infarction Pulido et al.[12]
Atrial fibrillation Pulido et al.[12], Berbari et al.[22]
Urinary tract infection Pulido et al.[12], Wilson et al.[10], Poss et al.[25]
Haematoma Pulido et al.[12], Jämsen et al.[21], Berbari et al.[22], Saleh et al.[23]
Continuous wound discharge Pulido et al.[12], Jämsen et al.[21], Berbari et al.[22]
Prolonged Hospital stay Pulido et al,[12]. Berbari et al.[22]
Table 1. Predisposing factors to PJI
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Organism Study (number of cases)
Buller
et al
[342]
Mahmud
et al [250]
Romano
et al [71]
Pulido
et al
[63]
Berbari
et al [462]
Phillips
et al [75]
Al-Maiyah
et al [106]
Salvati
et al
[2330]
Staphylococcus
MRSA 13.5% 3.2% 31% 19%
22%
4%
6.6% 27.3%
MSSA 19.6% 16% 21.1% 19% 25%
MRSE 2%
21.2% 22.5% 11% 19% 36% 68.9% 27.8%
MSSE 19.9%
α-Hemolytic Streptococcus 3.8%
2.8% 5.6% 12.7% 9% 7%
0.7%
β-Hemolytic Streptococcus 6.1% 7.2%
γ-Hemolytic Streptococcus 4.1% 5.6%
Enterococcus 2.9% 5.6% 1.6% 1.2% 9% 4.5%
VRE 0.6%
Streptococcus milleri 0.6%
Peptostreptococcus 2.4% 2.8% 12.3%
Gram-positive rods
Corynebacterium 0.3% 1.4% 1.6% 0.6% 3.2%
Enterobacter 4.1% 1.6% 1%
Propionibacterium 2.9% 0.8% 2.8% 1% 1.7%
Gram negative
Escherichia coli 3.2% 1.2% 3.2% 4% 0.9% 5.5%
Haemophilus 0.3%
Citrobacter koseri 0.3% 0.1%
Klebsiella 1.2% 3.2% 3% 1.3%
Proteus mirabilis 2.0% 1.6% 3.1%
Pseudomonas 3.2% 0.8% 5.6% 1.6% 4% 1.9% 5.6%
Salmonella 0.9% 1% 0.3%
Serratia marcescens 0.3% 1.2% 1.4% 1.6% 0.3%
Bacteroides fragilis 0.3% 0.4% 0.5%
Yeasts
Candida 0.3% 0.2% 0.3%
Diphteroids 1% 9.4% 0.9%
Polymicrobial 0.02% 6.3% 19%
Culture negative 8.8% 27.2% 9.5% 12%
No Results 22.4%
MRSA: Methicillin Resistant Staph. aureus, MSSA: Methicillin Sensitive Staph. aureus, MRSE: Methicillin Resistant Staph.
epidermis. MSSE: Methicillin Sensitive Staph. epidermis.
Table 2. Percentage of microbes in PJI [12, 20, 22, 31, 43-45, 48]
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While, the patient’s endogenous flora is largely held accountable for surgical site infections,
the surgical team personnel and operating room environment may also contribute to dis‐
perse organisms[49] and increase the bacterial count[18, 50]. Members of the surgical team
who have direct contact with sterile field have been linked to outbreaks of unusual organ‐
ism such as Serratia Marcescens[51]. Even though anesthesiologists, are not directly involved
in the operative field, they perform a variety of procedures related to the operation and have
been associated with outbreaks of bloodstream and surgical site infections linked to the re‐
use of propofol vials and other deviations from acceptable protocols[52].
2.3. Classification of PJI
The classification of PJI is based on, either the type of pathogenesis or the time of clinical
manifestation. When PJI are classified according to the pathogenesis, inoculation of the sur‐
gical site occurs either exogenously or haematogenously[11]. Exogenous infection, are infec‐
tions that occur during surgery or in the early post-operative period, usually in the presence
of large hematomas. Haematogenous infections are acquired through the bloodstream at
any time after surgery. As discussed in section 2.1, it has been reported that implants impair
the immune defenses and decrease the minimal abscess-forming dose of Staph. aureus at
least 10 000 fold both in an animal and human model[53, 54]. Patients with prosthetic joints
have a reported risk of 30 - 40% for haematogenous device–associated infection during
Staph. aureus sepsis[13, 42]. Even though patients, are mostly susceptible to PJI early after
implantation, haematogenous infection can occur at any time after surgery.
More commonly, PJI is classified according to the time of clinical manifestation after total
joint replacement. This classification is divided into 4 stages or groups[11, 55, 56]:
• Stage I or Early post-operative infection, which present acutely within the first 4 to 8
weeks after the operation
• Stage II or Delayed onset PJI and occurs between the 3rd month up to 24 months after surgery
• Stage III or Late onset PJI usually occur after 2 years from the procedure, the presentation
is usually sudden in an otherwise well-functioning joint.
• Stage IV or Silent infection when a positive culture is found at time of revision without
any previous evidence of infection.
Early (Stage I), delayed (Stage II) and silent (Stage IV) infections are commonly exogenous,
while stage I infections are probably caused by virulent microorganisms such as Staph. aur‐
eus and Escherichia coli, Stage II and Stage IV are typically caused by low virulent bacteria
such as coagulase negative staphylococci and Propionbacterium acnes[56, 57]. Stage III or Late
onset PJI occur acutely in a well-functioning joint and are caused by haematogenous spread.
The most common primary focus of infection is from skin and soft tissue infections, but
seeding from urinary, respiratory, gastrointestinal tract and dental infections are also report‐
ed[58]. In a recent report by Sendi et al., 57.5% of cases with haematogenous PJI had no
source identified either because of primary bacteremia, or because the primary infection has
already healed by the time signs and symptoms of PJI present[13].
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2.4. Definition of PJI
The Musculoskeletal Infection Society (MSIS) have recently analyzed the available evi‐
denced and proposed a set of criteria to define peri-prosthetic joint infection.
Based on these criteria[59], a definite PJI exists when:
i. there is a sinus tract communicating with the prosthesis; or
ii. a pathogen is isolated by culture from 2 or more separate tissue or fluid samples
obtained from the affected prosthetic joint; or
iii. when 4 of the following 6 criteria exist;
a. elevated serum erythrocyte sedimentation rate and serum C-reactive protein
(CRP) concentration,
b. elevated synovial white blood cell count,
c. elevated synovial polymorphonuclear percentage(PMN%),
d. presence of purulence in the affected joint
e. isolation of a microorganism in one culture of periprosthetic tissue or fluid, or
f. greater than 5 neutrophils per high-power field in 5 high-power fields ob‐
served from histologic analysis of periprosthetic tissue at ×400magnification.
PJI may be present if less than 4 of these criteria re not met and that in certain infections
with low virulent organisms such as Propionibacetium acnes, several of these criteria may not
be routinely met despite the presence of PJI.
3. Prevention of PJI
Both the host and environmental factors described previously (Table. 1) can affect the risk
for developing PJI. An effective strategy in preventing PJI is to improve both host and envi‐
ronmental factors during the pre, intra and post-operative period (Table. 3).
There are a number of host factors that increase the risk of PJI including conditions such as
diabetes, inflammatory arthropathy, preoperative anaemia, poor nutrition and obesity to
mention a few(Table. 1). Patients who present for elective orthopaedics procedures are in
suboptimal health. Furthermore, the impact of various risk factors appears to be accumula‐
tive, such that each factor has an individual affect to increase the risk of infection and has a
synergistic potential on the risk conferred by other factors[60, 61]. Thus, identifying such
risk factors and addressing them in the preoperative setting is critical in reducing PJI and
other postoperative complication.
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Time Strategy
Preoperative
Early Hostoptimization
Improve Diabetic control
Treat possible site of infections
Improve possible Medical Comorbidities
Obesity + Improve Nutritional Status
Pre – operative anaemia
Smoke Cessation
MRSA screening
Day of
Surgery
Surgical Site
Optimization
Surgical Site Shaving
Skin decolonisation (CHG wipes/showers)
Intraoperative
Surgical factors
Prophylactic antibiotics
Skin Preparation
Draping
Bleeding Control
Antibiotic impregnated cement
Skin Closure
Wound Dressing
Surgical team
Decolonization: Surgical scrubbing/rubbing
Impermeable Gowns/PPS
Double Gloving
OR environment
Operating Room Traffic
Laminar Airflow
Post-operative
Immediate
Antibiotics for 24 hours
Wound management
Blood Transfusion only where indicated
Management of medical complications
Late Antibiotic prophylaxis before invasive procedures
CHG: Chlorhexadine Gluconate, OR: Operating Room, PPS: Personal Protection System, MRSA: Methicillin Resistant
Staph. aureus Adopted from Matar et al. Preventing infection in total joint arthroplasty. J Bone Joint Surg Am. 2010;92
Suppl 2:36-46. Epub 2010/12/09.
Table 3. Preoperative, Intraoperative and Post-operative Strategies in preventing PJI
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3.1. Pre-operative period
3.1.1. Health optimization
Pre-operative optimization of health is of crucial importance to ensure a satisfactory out‐
come following total joint arthroplasty. ASA scores >2, diabetes and rheumatoid arthritis
among several factors have been associated with increased rates of perioperative complica‐
tions and PJI after total joint arthroplasty[9, 12, 20, 21, 24]. Lei et al. and Malinzak et al. have
both reported that diabetes and the total number of comorbidities were associated with a
higher risk of infection and that medical conditions have a synergistic effect on the risk of
developing a PJI[60, 62].
Prior to total joint arthroplasty, all patients should be assessed and managed in a multidisci‐
plinary pre-assessment clinic to optimize their general health. These have been shown to
significantly reduce both the post-operative mortality and costs per admission in orthopae‐
dic surgery[63]. Pre Assessment Clinics (PAC), focus on optimizing the host health in the
preoperative period such as improving nutritional status, optimizing diabetic control, car‐
diac and respiratory comorbidities and screening for possible source of infection and MRSA
decolonization. In our institution, all patients are assessed in the pre assessment clinic by a
consultant anesthesiologist, specialist nurse, nutritionist and physiotherapist, and if necessa‐
ry further consultation with other medical specialists such as cardiologist, rheumatologist or
neurologists is available to optimize the patients’ health preoperatively. The anesthetic con‐
sultant also follows the patient during hospitalization and during the post-operative period
whenever possible.
3.1.2. Bacterial decolonization
The Centre for Disease Control (CDC) guidelines for prevention of surgical site infection
(SSIs)  has strongly recommended that patients require to shower or bathe with an anti‐
septic  agent  on  at  least  the  night  before  the  operative  day  in  order  to  reduce  bacterial
load[64].  While  whole body bathing with antiseptic  has been shown to reduce bacterial
load of the skin as well as reducing the risk of infections[35, 65-67], it presents challeng‐
es in achieving entire body coverage and in maintaining sufficiently high concentrations
of solution on the skin for effective antisepsis[68]. Further more patient compliance with
these protocols is an issue[69]. Recent studies have addressed the effectiveness of preop‐
erative protocols with chlorhexidine gluconate (CHG) applied twice daily by patients at
home before their  joint  replacement[33,  70]  and one study reported reduction in SSI  in‐
fection from 3.19% to 1.59% after  the introduction of  2% CHG in place of  povidone io‐
dine antiseptic[71]. Based on the results of these studies, home skin preparation seems to
be a simple and cost effective technique in reducing PJI but patient compliance is an is‐
sue and further randomized control trials are required to fully understand the effect  on
preventing PJI.
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3.1.3. Prophylactic antibiotics
The benefits of prophylactic antibiotics have been widely reported in orthopaedic literature
[28-30, 72]. In 1970, Foldberg et al. compared a group treated prophylactically with penicillin
given preoperatively, intraoperatively and up to 5 days post operatively, with a control
group not treated with antibiotics; both groups underwent a mixture of mold arthroplasties
and spinal fusions[28]. The prevalence of infections was 1.7% in the treated group while
8.9% in the control group[28]. Furthermore during the period of the study these authors
have noticed an increase in the prevalence of MRSA in all major orthopaedic wound infec‐
tions, which demonstrates a delicate balance between the use and overuse of antibiotics in
the prevention and treatment of infections.
The most common organisms responsible for PJI have been already discussed in section 2.2,
and prophylactic antibiotics are targeted to cover this spectrum of organisms. Cefazolin and
cefuroxamine are the antibiotics of choice because of their good tissue penetration and excel‐
lent activity against Staphylococci and Streptococci. The American Association of Orthopae‐
dic Surgeons (AAOS) published guidelines regarding prophylactic choice, dosing and
optimal postoperative duration[61]. The AAOS recommendations for the use of intravenous
antibiotic prophylaxis are as follows:
• Recommendation 1: The antibiotic used for prophylaxis should be selected carefully, con‐
sistent with current recommendations in the literature, taking into account the issue of re‐
sistance and patient allergies. Currently, cefazolin and cefuroxamine are the preferred
antibiotics for patients undergoing orthopaedic procedures. Clindamycin and vancomy‐
cin may be used in patients with known β-lactam allergy. Vancomycin may be used in
patients with known colonization with MRSA or in facilities with recent MRSA outbreaks.
In multiple studies, exposure to vancomycin is reported as a risk in the development of
vancomycin resistant enterococcus (VRE) colonization and infection. Vancomycin should
be reserved fir the treatment of serious infection with β-lactam resistant organisms or for
treatment of infection in patients with life threatening allergy to β-lactam antimicrobials.
• Recommendation 2: Timing and dosage of antibiotics administration should optimize the
efficiency of the therapy. Prophylactic antibiotics should be administered within 1 hour be‐
fore skin incision. Owing to an extended infusion time, vancomycin should be started
within 2 hours before incision. If a proximal tourniquet is used, the antibiotic must be
completely infused before the inflation of the tourniquet. Dose amount should be propor‐
tional to the patients’ weight; for patients who weigh more than 80Kg, Cefazolin dose
should be doubled. Additional intraoperative doses of antibiotics are advised is [1] the
duration of the procedure exceeds one to two tines the antibiotic’s half-life or [2] there is
significant blood loss during the procedure. The general guidelines for frequency of intra‐
operative antibiotic administration are as follows: cefazolin every 2-5 hours, cefuroxamine
every 2-4 hours, clindamycin every 2-6 hours and vancomycin every 6-12 hours.
• Recommendation 3: Duration of prophylactic antibiotic administration should not exceed
the 24 hour postoperative period. Prophylactic antibiotics should be discontinued within 24
hours of the end of surgery. The medical literature does not support the continuation of
antibiotics until all drains or catheters are removed and provides no evidence of benefit
when they are continued past the 24 hours.
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3.2. Intra-operative period
3.2.1. Pre-operative hair removal
Pre-operative hair removal is of common practice, and a meta-analysis by the Cochrane group
showed that the relative risk of surgical site infection following hair removal with a razor was
significantly higher than that following hair removal with clippers, but there was no difference
reported in the rate of post-operative infections between procedures preceded by hair removal
and those performed without hair removal[73]. It is recommended that whenever hair is re‐
moved clippers rather than a razor should be used at the time of surgery[73].
3.2.2. Pre-operative skin preparation
3.2.2.1. Patients
Three main types of skin antiseptic agents are used; mainly chlorohexidine gluconate (CHG),
alcohol based solutions and povidone-iodine. Chlorohexidine is favored due to its long lasting
and cumulative activity against gram-positive and gram negative organisms found on human
flora. Povidone iodine it is also effective in reducing skin flora but in becomes ineffective on
contact with blood and duration of activity is shorter the CHG. Alcohol is an excellent antimi‐
crobial but its effectiveness is limited by the lack of any residual activity after drying and the
risk of flammability. A Cochrane meta-analysis carried out in 2004 showed no difference in ef‐
ficiency among skin antiseptics used in clean surgery[74]. Recent studies strongly suggest that
CHG combined with alcohol is superior to povidone-iodine combined with alcohol in antisep‐
sis for patients[75-77]. Ostrander et al. reported reduced bacterial count on feet prepared with
Chloraprep (2% CHG and 70% isopropyl alcohol; Medi-Flex, Overland Park, Kansas) than on
those prepared with Duraprep (0.7% iodin and 74% isopropyl alcohol; 3M Healthcare, St. Paul,
Minnesota) or Techni-Care[3.0% chloroxylenol; Care-Tech Laboratories, St. Louis, Missouri)
but there was no difference in infection rates among the 3 groups[77].
3.2.2.2. Surgeon
Antiseptic agents for surgeons can be classified into hand scrubs agents and hand rub
agents. Hand scrubs are typically solutions of CHG or povidone-iodine while hand rubs are
typically alcohol based solutions. Most data indicates that povidone–iodine and CHG have
equal efficacy in decreasing bacterial colony forming units from the skin of surgeons; fur‐
thermore no difference was found between hand rubs and hand scrub solutions[78, 79].
Some studies report better cost effectiveness of alcoholic hand rub by saving on water con‐
sumption and better physician compliance [78].
3.2.3. Draping
There is strong evidence in the literature for the use of plastic surgical adhesive tapes and
nonpermeable paper drapes for surgical site draping [16, 80-83]. Nonpermeable drapes are
used to prevent bacterial penetration during surgery, which was found to increase when tra‐
Arthroplasty - Update490
ditional cloth drapes got wet[80]. Iobhan iodophor-impregnated drapes (3M Health Care)
have been shown a reduction in wound contamination without any decrease in wound in‐
fection rate after total joint arthroplasty[84]. In their review of 4 000 patients in seven differ‐
ent trials, the Cochrane Wounds Group, found no evidence that adhesive drapes (plain or
impregnated with antimicrobials) reduce surgical site infection rates[85].
3.2.4. Double gloving
Sterile surgical gloves aim to protect the patient from contamination from residual bacteria
from members of the surgical team after hand scrubbing and protect the surgical team from
the patient’s body fluids[86]. Double gloving has been recommended because it has been
shown that it reduces perforations in the innermost glove especially in orthopaedic proce‐
dures where sharp surfaces are easily formed[86-88]. Beldame et al. have reported that, 80%
of glove perforations occur during surgical incision and changing the outer glove after sur‐
gical incision and before implantation of the prosthesis can reduce the risk of contamination
and perforation and resulted in a sterile state in 80% of cases[89].
3.2.5. Laminar flow, operating room traffic and personal protection system
Operating theatres are designed to reduce bacterial exposure to patients during surgery.
Vertical laminar airflow (LAF) provides directional airflow through a higher efficiency par‐
ticulate air (HEPA) filters and positive air pressure within the surgical field. Multiple stud‐
ies have reported reduced PJI rates with LAF[17, 90-92]. Brandt et al. reported no benefit
from using LAF, and it was even associated with increased risk of surgical site infection af‐
ter total hip arthroplasty. A recent systematic review on SSI following hip and knee arthro‐
plasty included 8 studies over the past 10 years and showed no improvement on PJI rates
and recommends against the installation of LAF systems in new operating theatres[93].
The opening of the operating room door disrupts the laminar airflow, allowing pathogens to
enter the space surrounding the site of the operation with increased risk of PJI[17, 94, 95].
Panahi et al. have reported a mean rate of 0.69 door opening per minute for primary and
0.84 openings per minute for revision total joint arthroplasty. Only 8% of the traffic was de‐
termined to be due to scrubbing in and out, demonstrating a high rate of unjustifiable traffic,
the authors further advise to implement strategies in reducing operating room traffic in an
attempt to decrease one etiology of PJI[18].
The human exhaust system or personal protection system (PPS) was initially introduced by
Sir J Charnley in the 1960s and designed to decrease airborne bacteria and intraoperative
contamination in total joint arthroplasty[96]. No uniform opinion exists with regard to the
use of PPS and the incidence of PJI[97-101]. One of the main issues with PPS is that, they are
bulky and tend to get contaminated. In a recent study, Kearns et al. have reported that 53
out of 102 PPS tested were contaminated with staphylococcus and one with MRSA, which
means that the PPS does not remain externally sterile in half of the cases[19]. These authors
recommend refraining from touching the PPS during surgery and the need to change gloves
if hand contact with the PPS occurs[19].
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3.2.6. Operative time
Long operative times have been found to increase the risk for PJI after total joint arthroplas‐
ty[27, 102, 103]. From a cohort of 9245 patients undergoing total joint arthroplasty, Pulido et
al reported longer operative time as a predisposing factor for PJI, a finding which is also
supported Kurtz et al. and Peersman et al[104, 105]. Furthermore, surgeons volume seems to
be inversely proportional to the rate of infection, were the higher the surgeon volume the
lower the rate of infection, but this was only found to be statistically significant after total
knee arthroplasty[26].
3.2.7. Addition of antibiotics to cement
In recent years antibiotic impregnated cement has become a standard for use in cemented
primary arthroplasty. According to recent studies, the rate of PJI was lower when a combi‐
nation of intravenous antibiotic prophylaxis and antibiotic impregnated cement was used
for primary cemented arthroplasty[21, 106]. Antibiotic impregnated cement seems to be of
particular use in the revision setting[107-109]. Nevertheless there is strong evidence to sup‐
port the efficiency of combined regime of prophylactic antibiotic and cement impregnated
antibiotic when compared to prophylactic antibiotic only in patients with other risk factors
for PJI[32, 110, 111].
3.2.8. Wound closure and surgical dressing
Various methods of skin closure are used in arthroplasty surgery, ranging from skin staples,
subcuticular closure with absorbable suture and recently the use of knotless barbed sutures.
A recent meta-analysis by Smith et al. reported that closure with skin staples had a signifi‐
cant risk of wound infection when compared to traditional suturing, but out of the six stud‐
ies reviewed only one study had acceptable methodology[112]. Newman et al has reviewed
181 patients after total knee arthroplasty and reported significant fewer complications after
closure with skin staples when compared with absorbable subcuticular sutures[113]. A pro‐
spective randomized control trial comparing staples to subcuticular absorbable suture and
tissue adhesives after TKA, showed highest superficial infection rate for subcuticular suture
(26%) and the lowest for skin staples (5%), although none of them required any treatment
with antibiotics[114]. Furthermore, staple based wound closure was fastest and the least ex‐
pensive after TKA but had the longest hospital stay when compared to the other meth‐
ods[114]. Recently there has been increased interest in knotless barbed sutures for wound
closure after total joint arthroplasty[115-117]. Most studies reported faster closure times for
the barbed sutures when compared to traditional methods[116, 117]. Patell et al. have re‐
ported a significant increase risk of major wound complications especially after TKA, when
barbed sutures (4.3%) were used compared to staples 1.1% and standard absorbable subcu‐
ticular closure (4.2%)[115]. However, debate still exists on which is the optimal method of
closure.
Surgical technique with careful tissue handling and wound closure is important in wound
healing, as well as the type of dressing that is applied postoperatively[118, 119]. Wound
Arthroplasty - Update492
dressing assist with healing by acting as a physical barrier to bacteria, splinting the wound
to protect it from subsequent injury, helping with haemostasis, reducing dead space and
minimizing pain. The use of occlusive dressings is well known to improve re-epithelisation
and subsequent collagen synthesis when compared to wound exposed to air[120, 121]. In a
recent Cochrane review, Dumville et al. reported no evidence to suggest that one dressing is
better than any other in preventing surgical site infection and advised that the choice of
dressing should be based on costs and the need for management of specific symptoms[122].
After total joint arthroplasty, a hydrofiber/hydrocolloid dressing using the jubilee method
has been shown to reduce the rate of blister formation but no significant reduction in surgi‐
cal site infection[118]. Burke et al. have carried out a prospective randomized study compar‐
ing the jubilee dressing method with standard adhesive dressing after total joint
arthroplasty and reported a significant reduction in blister formation, leakage and dressing
changes in the group treated with the jubilee method but no significant reduction in SSI. The
authors of this study recommend the use of the hydrofiber/hydrocolloid dressing combina‐
tion after total joint arthroplasty due to the associated lower complication rate[123].
3.3. Post-operative period
Most medical complications in the post-operative period have been to increased rates of PJI,
mainly elevated blood creatinine levels, allogenic blood transfusion, myocardial infarction,
atrial fibrillation and urinary tract infections[9, 10, 12, 21, 22, 25]. Adequate hydration is crit‐
ical in post-operative period and allogenic blood transfusion is indicated in the presence of
symptomatic anaemia, a haemoglobin level <8g/dL, or when it is medically indicated[124].
Control and monitoring of blood sugar levels is important in diabetic patients and should
follow the same principles used in the preoperative period. Persistent wound drainage has
been has been found as a contributing factor in the development of PJI[12, 21, 22], however
there is little or no supportive evidence for the continues use of antibiotics[61] or antimicro‐
bial impregnated dressings[122]. Furthermore, post-operative complication can result in de‐
layed rehabilitation after a total joint arthroplasty with resultant delay in discharge from
hospital, which has been reported by various studies as a risk factor for the development of
PJI[12, 22].
4. Diagnosing PJI
Currently there is no diagnostic modality, which is 100% reliable in diagnosis PJI. An assess‐
ment using a combination of clinical findings and investigations is necessary.
4.1. Clinical
A careful history and physical examination are crucial in making a diagnosis of PJI. Al‐
though the diagnosis of early postoperative or acute haematogenous infection is not diffi‐
cult, late infections can be challenging to distinguish from other causes of pain in a patient
with previous total joint arthroplasty. Clinically, early or acute infections are characterized
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by pain, fever, wound drainage or erythema. While the only feature of chronic infection, can
be pain unrelieved by a seemingly well-functioning arthroplasty. Loosening during the first
year post implantation or a consistently painful arthroplasty should be considered infected
until proven otherwise.
4.2. Diagnostic investigations
4.2.1. Serology
Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) are baseline screening
tests for any patient planned for revision arthroplasty regardless of the cause of failure[5].
Diagnostic value of ESR and CRP has been widely reported, and their combined use is a
very good ‘rule out’ test [125, 126]. When both ESR and CRP are negative, periprosthetic in‐
fection is unlikely, however when both tests are positive PJI must be considered, and this
warrants further investigations [5]. Ghanem et al. have reported that values higher than an
ESR of 30 mm/h and CRP 10 mg/l combined to gather had 97.6% sensitivity for a positive
diagnosis of PJI[127].
A full blood count including a white blood cell (WBC) count is part of the routine workout
for patients with suspected PJI, however recent evidence suggests that serum WBC and dif‐
ferential carries a very low sensitivity (55% and 52% respectively) and specificity (66% and
75% respectively)[128]. Accordingly, routine serum WBC count and differential have no role
in the diagnosis of PJI..
4.2.2. Joint aspiration
Joint  aspiration  is  recommended  as  part  of  the  work  up  in  diagnosing  PJI  in  patients
with combined elevation of ESR and CRP levels in the hip and elevation of ESR and/or
CRP levels in the knee joint[5]. Joint aspiration is usually carried out under sterile condi‐
tions,  and synovial  fluid  should be  for  culture  and sensitivity,  WBC count  and neutro‐
phil percentage. Some patients with abnormal ESR and CRP may require more than one
aspiration. A WBC count higher than 1700 cell/µl or a neutrophil percentage greater than
65% is  highly  suggestive  of  chronic  PJI,  however  these  values  are  not  applicable  when
diagnosis acute PJI[129, 130]
4.2.3. Imaging studies
Imaging studies such as plain radiographs, computed tomography (CT) or magnetic reso‐
nance imaging (MRI) scans are useful in sub classifying patient into high and low probabili‐
ty of PJI. Radiolucent lines, focal osteolysis, periosteal bone formation or early loosening
may all suggest PJI[131], however differentiating between PJI and aseptic loosening may not
be possible using imaging modalities on their own. Nuclear scintigraphy detects inflamma‐
tion in peri-prosthetic tissue, and although technetium-99m bone scintigraphy has very high
sensitivity, it lacks specificity for infection[132]. A technetium bone scan can remain positive
more than a year after implantation because of increased periprosthetic bone remodelling.
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Love et al. reported increased sensitivity (96%), specificity (87%) and accuracy (91%) when a
leukocyte/marrow scintigraphy was used to identify PJI. The test was significantly more ac‐
curate than bone (50%), bone/gallium (66%) and leuckocyte/bone (70%) scintigraphy in diag‐
nosing PJI[133]. It seems that a Leukocyte/marrow scintigraphy will remain the procedure of
choice in diagnosing PJI until agents capable of differentiating infection from aseptic inflam‐
mation are developed[133].
 
Figure 1. Plain AnteroPosterior and Lateral Radiographs showing focal areas of osteolysis, suspicious of PJI.
4.2.4. Intraoperative techniques
Various techniques can be used intraoperatively during revision arthroplasty to diagnose in‐
fection. These techniques include synovial fluid biomarkers, cultures and frozen sections.
4.2.4.1. Cultures and Gram stain
Cultures of periprosthetic tissues provide the most reliable means of detecting that pathogen
and are often used as a reference standard in diagnosing PJI. Multiple samples should be
taken at the time of the procedure from various regions, at least 3 samples for culture are
recommended[134-136]. Cultures may be negative because prior antibiotic exposure, low
number of organisms, an inappropriate culture medium, fastidious organisms or prolonged
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transport time to the laboratory[11]. Grams stains have high specificity (97%) but extreme
low sensitivity (less than 26%)[137, 138]. The AAOS guidelines recommend against the rou‐
tine use of intraoperative gram stain for the diagnosis of PJI[5].
4.2.4.2. Frozen sections
A meta-analysis by Della Valle et al reported that frozen sections are very good in ruling in
but have low value in ruling out and infection[5]. These studies have more than 80% sensi‐
tivity and more than 90% specificity, but they also have high interobserver variability. The
degree of inflammatory cells infiltrations varies among specimens from the same patient,
sometimes even within individual tissue samples[11].
4.2.4.3. Synovial fluid biomarkers
Synovial fluid can used to analyse for various biomarkers such as leukocyte esterase, syno‐
vial CRP and white blood cell count, interleukin 6 (IL-6) and interleukin 8 (IL-8). Leukocyte
esterase is an enzyme secreted by activated neutrophils that migrate at the site of infections.
This enzyme is usually found on colorimetric dipsticks to diagnose urinary tract infections.
Potential advantages of this diagnostic tool include wide availability, low cost and potential
of an accurate diagnosis within minutes. Parvizi et al. have initially reported preliminary da‐
ta on using leukocyte esterase as a diagnostic tool. These authors reported 80.6% sensitivity
and 100% specificity in diagnosing PJI, with 100% positive predictive value and 93.3% nega‐
tive predictive value[139]. Wetters et al also reported similar results when they used leuko‐
cyte esterase for diagnosis PJI[140]. In both studies, the leukocyte esterase strip was
unreadable in on third off cases due to synovial blood or debris. Even though, these results
are promising, both of these studies have their limitations in the methodology used, and fur‐
ther on, none of studies identifies whether the leukocyte esterase strip is able to differentiate
between inflammation and infection.
Measurement of synovial CRP has been shown to be a sensitive (85%) and specific (95%)
marker in diagnosis PJI[141, 142]. Recent studies report IL-6 levels to be more accurate in
diagnosis PJI than ESR, CRP level, or synovial fluid WBC count and can be useful in diagno‐
sis of PJI in patients with confounding systemic variables. Jacovides et al. have also reported
higher specificity and sensitivity for both IL-6 (100% and 87.1%) and IL-8 (97.7% and 90.3%)
when compared to synovial CRP (97.7% and 87.1%)[143]. Based on these studies synovial
fluid biomarkers could provide an additional valuable resource for the diagnosis of PJI, but
further studies are required.
4.3. AAOS guidelines
The American Academy of Orthopaedic Surgeons (AAOS), based on the current clinical evi‐
dence, has proposed clinical guidelines in the diagnosis of peri-prosthetic joint infec‐
tion[144]. On the bases of the clinical features, the patients are classified into those who have
a high or low probability of PJI (Table 4). The guidelines consist of 15 recommendations,
with the majority being supported strongly in the literature. The guidelines advocate an al‐
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gorithmic approach to the diagnosis of PJI, beginning with baseline investigations such the
Erythrocyte Sedimentation Rate (ESR) and the C Reactive Protein (CRP) that carry high sen‐
sitivity and specificity when combined together[125, 126].
Higher Probability of
Infection
One or more symptoms, AND at least one or more:
• risk factor* OR
• physical exam finding; OR
• early implant loosening/osteolysis (as detected by x-ray)
Lower Probability of
Infection
Pain or joint stiffness only and none of the following:
• risk factors;* OR
• physical exam findings; OR
• early implant loosening/osteolysis (as detected by x-ray)
*risk factor supported by evidence or expert opinion. Adopted from the AAOS clinical practice guidelines for the diag‐
nosis of periprosthetic infections[144]
Table 4. Stratification of patients into High or low probability of infection[144]
Further investigations, such as joint aspiration, are recommended in a stepwise manner de‐
pending on the ESR and CRP levels. The AAOS clinical guidelines and algorithms for the
diagnosis peri-prosthetic infections, are available free to download from http://
www.aaos.org/research/guidelines/guide.asp.
5. Management of PJI
The management of total joint arthroplasty consists of one or more of the following techni‐
ques:
i. Antibiotic therapy
ii. Debridement and Irrigation of the joint with component retention or linear ex‐
change
iii. Single Stage Revision Arthroplasty (SSRA)
iv. Two Stage Revision Arthroplasty (TSRA)
v. Arthrodesis
vi. Amputation
Management decisions are made on severity, chronicity of the infection, virulence of the in‐
fecting organism, status of surrounding soft tissue and physiological status of the patient.
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5.1. Unexpected positive intraoperative cultures
Unexpected positive intraoperative cultures are found in cases where pre-operative assess‐
ment fails to show infection, these cases usually undergo revision for aseptic loosening. Tsu‐
kayama eta al. reported up to 11% of cases were infection was diagnosed with positive
intraoperative cultures and were all treated with 6 weeks of antibiotics without additional
operation. Antibiotic therapy failed in 3 of these cases, and the patients required further sur‐
gical treatment with 2 patient showing evidence of recurrent infection at 2 year follow
up[56]. In another study, 15 patients with positive intraoperative cultures were not treated
with antibiotics, recurrence of infection was reported in 6 patients[145]. Based on these stud‐
ies, patients with unexpected positive cultures should be treated with antibiotics for 6 weeks
while monitoring their ESR and CRP values to assess response to treatment under the super‐
vision of a specialist microbiologist[146].
5.2. Antibiotic suppression
When patients have poor state of health, have a high risk of complications after surgery
and the infective organism is of low virulence and susceptible to antibiotic therapy, sup‐
pression by antibiotic  alone may be the best  option.  Rao et  al.  investigated the rates  of
eradication of antibiotic resistant organisms with suppression therapy and noted eradica‐
tion in 86% at mean follow up of five years, with five recurrent infections all within the
first  3  years[147].  Antibiotic  suppression  is  also  indicated  in  patient  with  persistent  PJI
following  surgical  intervention  if  they  decline  or  cannot  tolerate  further  surgery[6,  11,
148, 149].  The literature on antibiotic suppressive therapy without any surgical interven‐
tion is poor; despite this, patients who cannot tolerate surgery have no other option than
suppressive therapy.
5.3. Debridement and Irrigation with component retention or linear exchange
Operative  debridement  and  irrigation  with  component  retention  should  be  reserved  of
acute infections (Stage II and occasionally stage III). Early infections may range in severi‐
ty  from  superficial  cellulitis  to  deep  infections.  Superficial  infections  associated  with
wound dehiscence or purulent drainage and infections with wound necrosis  or  infected
haematomas often require  surgical  debridement.  Reported eradication rate  has  been be‐
tween  24%  to  71  %  following  open  debridement  and  irrigation[56,  150,  151].  Even
though, some case reports show excellent results from irrigation and debridement[152], a
recent multicentre retrospective study showed that irrigation and debridement with com‐
ponent  retention is  not  affected by organism type and that  this  technique had a failure
rate  as  high  as  70%,  with  the  authors  questioning  the  actual  role  of  irrigation  and de‐
bridement  in  the  treatment  of  PJI[151].  Prostheses  retention  is  also  contraindicated  in
those with multiple joint arthroplasty or when the duration of symptoms is more than 1
month[7, 15].
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5.4. Single stage revision arthroplasty
Single stage revision with removal of components, debridement, irrigation and reimplantation
of new components provides removal of infected prosthesis while limiting the number of sur‐
geries, recovery time and costs. Callaghan et al. reports 8.3% rate of recurrence after single
stage revision arthroplasty with a minimum follow up of 10 years[153]. The local therapy, is
achieved by adding antibiotics to the cement used for fixation of the implant, this is followed by
a minimum of 6 weeks antibiotic therapy. Two studies comparing one-stage to two stage revi‐
sion arthroplasty favoured the two stage technique[154, 155]. Failure rates in SSRA ranged
from 10.1% to 12.4%, compared to 3.5% to 5.6% in TSRA. A recent meta-analysis comparing
SSRA to TSRA reported the presence of nearly three additional reinfections per 100 revisions
when performing a one stage compared to a two stage procedure[156]. However, not enough
evidence is available to demonstrate that one technique is superior to the other[156].
5.5. Two stage revision arthroplasty
Two stage revision arthroplasty (TSRA) is currently the gold standard technique for the
treatment  of  infected  joint  arthroplasty[107,  157-159].  TSRA  involves  initial  removal  of
the  infected  components  and  all  foreign  material  including  cement,  cement  restrictors
and cables  or  wires  whenever  possible  with meticulous debridement  and irrigation.  All
necrotic tissue is excised, and sinus tracts are debrided. After irrigation the joint should
be inspected for any remaining debris.  A cement spacer loaded with antibiotics is used,
this  is  either  pre-manufactured or  constructed at  the  time of  surgery[160,  161].  Various
techniques described in  the construction of  a  cement  loaded spacer,  the  technique used
depends  on  the  joint  involved  and  the  level  of  bone  loss  encountered  during  the  first
stage[109, 161-164]. These custom spacers allow antibiotic elution locally to eradicate the
infective  organism  and  maintain  soft  tissue  balance  to  accommodate  the  definitive  im‐
plant during the second stage.  A minimum course of six weeks of antibiotics is  usually
required,  and resolution  of  infection  is  confirmed through serial  ESR and CRP and re‐
peated aspiration of the joint. A further aspiration of the joint before the second stage is
recommended in one study, which reported recurrence rate of 3% among those who un‐
derwent aspiration compared with 14% in those who did not[165].
The advantages of TSRA[166] include:
i. meticulous debridement of soft tissue, necrotic bone and cement during the first
stage and during the second stage before reimplantation
ii. identification of offending organism, sensitivities are determined and appropriate
antibiotic therapy is given for a prolonged period before reimplantation
iii. evaluation of distant foci of infection and eradication of sites responsible for hae‐
matogenous spread
iv. informed decision can be made as to whether the degree of disability from resec‐
tion arthroplasty or arthrodesis would justify the risks involved in the implantation
of a new prosthesis
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The disadvantages[166] include:
i. prolonged period of disability and hospital stay
ii. increased costs
iii. delayed rehabilitation
iv. technically difficult second procedure due to loss soft tissue balance, loss of bone
stock shortening and scarring
TSRA has been associated with lower rates of recurrent infections in most studies[6, 167,
168]. The duration of antibiotics between the two stages has not been determined, but a min‐
imum of 6 weeks is usually standard and is guided by serial ESR and CRP levels. Manage‐
ment of bone stock deficiency at the time of revision is a problem. Impaction bone grafting
with cemented prosthesis has been used for reconstruction during the second stage with
good results. English et al. reported eradication in 49 out of 53 cases treated with impaction
bone grafting during the second stage with a minimum follow up of 2 years[169] and a re‐
currence rate up to 7.5%[169, 170]. Use of antibiotic loaded cement for fixation of the implant
during the second stage has been shown to reduce rates of reinfection. Garvin et al. reported
eradication in 95% of patients at 5 year interval when gentamicin loaded cement was utilis‐
ed during the second stage[171]. Highest success rates for TSRA were found for patients
treated with antibiotics-eluting spacer or beads between the first and second stage, followed
by a second reconstruction with an antibiotic loaded cemented reconstruction[55, 167, 172].
Data on uncemented implants has generally been less positive, with early studies reporting
rates of infection as high as 18% and additional cases of loosening[43, 173]. Studies that are
more recent have reported reinfection rates between 6% and 11%[174]. The decision regard‐
ing cemented or uncemented reimplantation is guided by the available bone stock, physio‐
logical age and expected longevity of the patient. To minimize loss of bone stock during the
first stage, the Exeter group adopted a cement in cement revision technique for hip arthro‐
plasty, where an excision arthroplasty with antibiotic impregnated cement beads is carried
out during the first stage. In this technique if the cement mantle from the previous arthro‐
plasty is well fixed, is left alone. During the second stage, the cement beads are removed,
and the existing cement mantle is reamed to remove any membrane or microfilm and to cre‐
ate space for the new antibiotic augmented cement and the new implant. Sixteen patients
with at least three years follow up underwent this procedure with one patient requiring re‐
vision due to recurrent infection[175].
5.6. Arthrodesis and amputation
Salvage procedures are reserved for patients whose medical condition such as immunocom‐
promised patients or in patients where successful reconstruction is impossible. Successful
reconstruction is limited those patients with insufficient bone stock, inadequate muscle
function and poor soft tissue coverage. Eradication of infection after salvage procedures is
reported between 86% to 96% although they are usually associated with poor functional out‐
comes[176-178]. Above knee amputation provides good return to function with a fitted pros‐
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thesis, especially in patients who cannot tolerate multiple procedures. Arthrodesis allows
the patient to retain the extremity at the cost of reducing ambulation especially in patients
with a fused knee.
6. Conclusion
Infection of a total Joint arthroplasty is considered a major complication in orthopaedic sur‐
gery with significant morbidity and places a considerable burden on hospitals and surgeons.
Prevention is better than treatment and improving the patients’ health prior to surgery is
important in reducing the risk of infection. Furthermore, prompt diagnosis, permits early
treatment that is important in acute infections. In the absence of a perfect test, the evidence
based algorithmic approach brought forward by the AAOS guidelines should enable diag‐
nosis of infection to be made with a high degree of confidence. There is clearly a role for sur‐
gical intervention, and so far a two-stage revision arthroplasty demonstrates the lowest rates
of recurrent infection and as such is regarded as the ‘gold standard’.
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